Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CVS Caremark Corp. (NYSE: CVS) | Delayed: 79.96 -11.45 (12.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.41 | 52 Week High | $106.67 | |||
| Open | $85.30 | 52 Week Low | $69.30 | |||
| Day High | $85.30 | P/E | 21.32 | |||
| Day Low | $77.33 | EPS | $3.75 | |||
| Volume | 34,273,106 | |||||
